NCT03026517 Clinical Trial of Phenformin in Combination With BRAF Inhibitor + MEK Inhibitor for Patients With BRAF-mutated Melanoma Status COMPLETED Phase PHASE1
NCT03007823 High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT03002376 An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1) Status COMPLETED Phase PHASE1
NCT02990611 Observational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab Therapy Status COMPLETED Phase N/A
NCT02989064 MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers Status COMPLETED Phase PHASE1
NCT02988817 Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02986867 SAbR Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma Status COMPLETED Phase NA
NCT02983045 A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02983006 Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE1
NCT02978404 Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases Status COMPLETED Phase PHASE2
NCT02975700 A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma Status COMPLETED Phase NA
NCT02974803 Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases Status TERMINATED Phase PHASE2
NCT02974725 A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma Status TERMINATED Phase PHASE1
NCT02970981 Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma Status COMPLETED Phase PHASE2
NCT02968680 Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma Status TERMINATED Phase PHASE1
NCT02967692 A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma Status TERMINATED Phase PHASE3
NCT02962947 MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients Status UNKNOWN Phase PHASE2/PHASE3
NCT02949154 Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma Patients Status COMPLETED Phase N/A